288 related articles for article (PubMed ID: 27701405)
1. Membrane lipidomics in schizophrenia patients: a correlational study with clinical and cognitive manifestations.
Tessier C; Sweers K; Frajerman A; Bergaoui H; Ferreri F; Delva C; Lapidus N; Lamaziere A; Roiser JP; De Hert M; Nuss P
Transl Psychiatry; 2016 Oct; 6(10):e906. PubMed ID: 27701405
[TBL] [Abstract][Full Text] [Related]
2. [Membrane lipids in schizophrenia and early phases of psychosis: Potential biomarkers and therapeutic targets?].
Frajerman A; Kebir O; Chaumette B; Tessier C; Lamazière A; Nuss P; Krebs MO
Encephale; 2020 Jun; 46(3):209-216. PubMed ID: 32151446
[TBL] [Abstract][Full Text] [Related]
3. Subthreshold social cognitive deficits may be a key to distinguish 22q11.2DS from schizophrenia.
Peyroux E; Rigard C; Saucourt G; Poisson A; Plasse J; Franck N; Demily C
Early Interv Psychiatry; 2019 Apr; 13(2):304-307. PubMed ID: 29575660
[TBL] [Abstract][Full Text] [Related]
4. Abnormal transbilayer distribution of phospholipids in red blood cell membranes in schizophrenia.
Nuss P; Tessier C; Ferreri F; De Hert M; Peuskens J; Trugnan G; Masliah J; Wolf C
Psychiatry Res; 2009 Sep; 169(2):91-6. PubMed ID: 19646766
[TBL] [Abstract][Full Text] [Related]
5. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
6. Differential relationships between positive and negative symptoms and neuropsychological deficits in schizophrenia.
Berman I; Viegner B; Merson A; Allan E; Pappas D; Green AI
Schizophr Res; 1997 May; 25(1):1-10. PubMed ID: 9176922
[TBL] [Abstract][Full Text] [Related]
7. The membrane hypothesis of schizophrenia.
Horrobin DF; Glen AI; Vaddadi K
Schizophr Res; 1994 Oct; 13(3):195-207. PubMed ID: 7841132
[TBL] [Abstract][Full Text] [Related]
8. Impaired Membrane Lipid Homeostasis in Schizophrenia.
Li M; Gao Y; Wang D; Hu X; Jiang J; Qing Y; Yang X; Cui G; Wang P; Zhang J; Sun L; Wan C
Schizophr Bull; 2022 Sep; 48(5):1125-1135. PubMed ID: 35751100
[TBL] [Abstract][Full Text] [Related]
9. Deficits in cue detection and intention retrieval underlie prospective memory impairment in schizophrenia.
Woods SP; Twamley EW; Dawson MS; Narvaez JM; Jeste DV
Schizophr Res; 2007 Feb; 90(1-3):344-50. PubMed ID: 17175138
[TBL] [Abstract][Full Text] [Related]
10. Concurrent validity of the cognitive component of schizophrenia: relationship of PANSS scores to neuropsychological assessments.
Bell MD; Lysaker PH; Milstein RM; Beam-Goulet JL
Psychiatry Res; 1994 Oct; 54(1):51-8. PubMed ID: 7701028
[TBL] [Abstract][Full Text] [Related]
11. A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases.
Glen AI; Glen EM; Horrobin DF; Vaddadi KS; Spellman M; Morse-Fisher N; Ellis K; Skinner FS
Schizophr Res; 1994 Apr; 12(1):53-61. PubMed ID: 8018585
[TBL] [Abstract][Full Text] [Related]
12. Phospholipid patterns of erythrocytes in schizophrenia: relationships to symptomatology.
Ponizovsky AM; Modai I; Nechamkin Y; Barshtein G; Ritsner MS; Yedgar S; Lecht S; Bergelson LD
Schizophr Res; 2001 Oct; 52(1-2):121-6. PubMed ID: 11595399
[TBL] [Abstract][Full Text] [Related]
13. Phospholipid membrane abnormalities and reduced niacin skin flush response in schizophrenia.
Buretić-Tomljanović A; Giacometti J; Nadalin S; Rubesa G; Vulin M; Tomljanović D
Psychiatr Danub; 2008 Sep; 20(3):372-83. PubMed ID: 18827766
[TBL] [Abstract][Full Text] [Related]
14. Cognitive impairments in first-episode drug-naive and chronic medicated schizophrenia: MATRICS consensus cognitive battery in a Chinese Han population.
Wu JQ; Chen DC; Tan YL; Xiu MH; De Yang F; Soares JC; Zhang XY
Psychiatry Res; 2016 Apr; 238():196-202. PubMed ID: 27086233
[TBL] [Abstract][Full Text] [Related]
15. Neurocognitive profile and its association with psychopathology in first-degree relatives of patients with schizophrenia. a case-control study.
Scala S; Lasalvia A; Cristofalo D; Bonetto C; Ruggeri M
Psychiatry Res; 2012 Dec; 200(2-3):137-43. PubMed ID: 22652345
[TBL] [Abstract][Full Text] [Related]
16. Sex differences in olfactory identification and Wisconsin Card Sorting performance in schizophrenia: relationship to attention and verbal ability.
Seidman LJ; Goldstein JM; Goodman JM; Koren D; Turner WM; Faraone SV; Tsuang MT
Biol Psychiatry; 1997 Jul; 42(2):104-15. PubMed ID: 9209727
[TBL] [Abstract][Full Text] [Related]
17. Comparative neuropsychological function in obsessive-compulsive disorder and schizophrenia with and without obsessive-compulsive symptoms.
Whitney KA; Fastenau PS; Evans JD; Lysaker PH
Schizophr Res; 2004 Jul; 69(1):75-83. PubMed ID: 15145473
[TBL] [Abstract][Full Text] [Related]
18. Metabolomics and lipidomics analyses by
Tasic L; Pontes JGM; Carvalho MS; Cruz G; Dal Mas C; Sethi S; Pedrini M; Rizzo LB; Zeni-Graiff M; Asevedo E; Lacerda ALT; Bressan RA; Poppi RJ; Brietzke E; Hayashi MAF
Schizophr Res; 2017 Jul; 185():182-189. PubMed ID: 28040324
[TBL] [Abstract][Full Text] [Related]
19. Membrane phospholipid metabolism and schizophrenia: an in vivo 31P-MR spectroscopy study.
Stanley JA; Williamson PC; Drost DJ; Carr TJ; Rylett RJ; Morrison-Stewart S; Thompson RT
Schizophr Res; 1994 Oct; 13(3):209-15. PubMed ID: 7841133
[TBL] [Abstract][Full Text] [Related]
20. Β-Amyloid Burden is Not Associated with Cognitive Impairment in Schizophrenia: A Systematic Review.
Chung JK; Nakajima S; Plitman E; Iwata Y; Uy D; Gerretsen P; Caravaggio F; Chakravarty MM; Graff-Guerrero A
Am J Geriatr Psychiatry; 2016 Oct; 24(10):923-39. PubMed ID: 27526990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]